MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Combined effect of polygenic background and GBA Pathogenic variants in Parkinson’s disease risk

    Z. Landoulsi, E. Hassanin, S. Pachchek, DB. Bobbili, P. May (Esch-sur-Alzette, Luxembourg)

    Objective: We aimed to investigate whether polygenic background affects the penetrance of Parkinson’s disease (PD) among carriers of heterozygous pathogenic variants (PV) in GBA. Background: Several rare homozygous mutations within…
  • 2023 International Congress

    Potential role of Alpha-synuclein levels in Platelets in GBA-related PD

    G. Uras, S. Lucas, A. Schapira (London, United Kingdom)

    Objective: Identification of a blood biomarker to predict PD diagnosis or to monitor the disease progression. Background: Previous evidence suggests differences in systemic alpha-synuclein levels…
  • 2023 International Congress

    Neuropsychological and quality of life outcome comparison after awake and asleep pallidal deep brain stimulation (DBS) surgery for Parkinson’s disease

    A. Tröster, A. Novak, S. Russell, K. Hanson (Phoenix, USA)

    Objective: To compare cognitive, psychiatric and quality of life (QoL) outcomes after awake and asleep bilateral pallidal (GPi) deep brain stimulation (DBS). Background: Prior studies…
  • 2023 International Congress

    Dopamine depletion of striatal subregions and motor dysfunction in prodromal and clinical Parkinson’s disease

    M. Banwinkler, M. Hoenig, V. Dzialas, T. van Eimeren (Cologne, Germany)

    Objective: This aim of this study was to investigate how dopamine depletion of different striatal subregions contributes to motor symptoms in patients with prodromal and…
  • 2023 International Congress

    REM sleep behaviour disorder in Parkinson’s disease: prevalence and correlation with other sleep parameters

    S. Diaconu, L. Ungureanu, A. Zarnoveanu, B. Ciopleias, V. Vasile, A. Iacob, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to assess the prevalence of probable rapid eye movement (REM) sleep behavior disorder (RBD) in Parkinson’s disease (PD) patients and its correlation with other…
  • 2023 International Congress

    Vagus nerve degeneration in Parkinson’s disease: correlation with autonomic symptoms and pupillography

    M. Batchakaschvili, M. Löhle, HR. Kleinlein, W. Hermann, H. Walter, A. Storch, U. Walter (Rostock, Germany)

    Objective: To test the hypothesis that vagus nerve (VN) atrophy is pronounced in the body-first subtype of Parkinson’s disease (PD) and coincides with pupillary dysfunction.…
  • 2023 International Congress

    Filipino’s and Parkinson’s Disease: A Scoping Review of the Literature

    E. Krening, T. Seto, M. Bruno (Honolulu, USA)

    Objective: To review the literature on Parkinson’s disease (PD) in Filipino’s and identify specific studies focusing on Filipino-Americans and Parkinson’s disease. Background: Filipino’s are the…
  • 2023 International Congress

    Online recruitment and retention in the Parkinson’s Progression Markers Initiative (PPMI)

    C. Tanner, E. Brown, L. Chahine, D. Weintraub, R. Dobkin, W. Poewe, E. Tolosa, C. Marras, S. Schade, C. Coffey, M. Korell, C. Stanley, J. Valdeverde Twiggs, M. Kuhl, K. Fabrizio, S. Chowdhury, T. Sherer, A. Siderowf, T. Simuni, K. Marek (SAN FRANCISCO, USA)

    Objective: To describe participants and retention in the longitudinal PPMI Online cohort Background: The overall PPMI aim of biomarker identification to enable therapeutic development is…
  • 2023 International Congress

    MR-guided focused ultrasound pallidothalamic tractotomy in non-tremor dominant (akinetic-rigid) Parkinson’s disease treatment

    R. Galimova, G. Akhmadeeva, D. Nabiullina, F. Kashapov, O. Kachemaeva, YU. Sidorova, D. Teregulova, N. Mukhamadeeva, D. Krekotin, I. Buzaev, SH. Safin, S. Illarioshkin (Ufa, Russian Federation)

    Objective: The study aims to show that unilateral MR-guided focused ultrasound (MRgFUS) treatment akinetic-rigid Parkinson's disease (PD) can be safe and effective. Background: Parkinson's disease…
  • 2023 International Congress

    From the Healthy Brain Ageing (HeBA) Cohort: Frequency of key risk factors for Parkinson in a European Cohort

    A. Garrido, C. Horlings, C. Vega, S. Schade, S. Ghosh, K. Rege, R. Rawal, T. Marques, P. Mahlknecht, C. Gomes, C. Pauly, D. Mcintyre, K. Seppi, MJ. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: To present the baseline data on common risk factors for Parkinson’s disease (PD) in the population-based cohort of the HeBA study (Ref Poster 1)…
  • « Previous Page
  • 1
  • …
  • 200
  • 201
  • 202
  • 203
  • 204
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley